Corporate News 20-Dec-17
Morepen Laboratories gets USFDA clearance for its bulk drug Montelukast Sodium
For sale in US market
Morepen Laboratories announced that USFDA has cleared Montelukast Sodium, a bulk drug/ API manufactured by Morepen Laboratories for sale in the US market. This gives Morepen an entry into the Rs 2000 crore (approx. $300 million) US market for Montelukast. The first commercial order for the bulk drug are expected in Q2 of FY 2018-19.
Previous News
Morepen Laboratories consolidated net profit rises 34.47% in the September 2023 quarter
( Results - Announcements 02-Nov-23 15:38 )
Morepen Laboratories standalone net profit rises 2.82% in the March 2020 quarter
( Results - Announcements 22-Jun-20 17:03 )
Morepen Laboratories schedules AGM
( Corporate News - 12-Sep-24 16:01 )
Morepen Laboratories EGM scheduled
( Corporate News - 26-Feb-24 10:28 )
Morepen Laboratories consolidated net profit rises 119.87% in the December 2020 quarter
( Results - Announcements 12-Feb-21 18:28 )
Morepen Laboratories consolidated net profit rises 5.05% in the March 2020 quarter
( Results - Announcements 22-Jun-20 17:19 )
Morepen Laboratories to convene AGM
( Corporate News - 06-Sep-21 10:11 )
Morepen Laboratories Ltd leads gainers in 'A' group
( Hot Pursuit - 30-Jun-22 12:00 )
Morepen Laboratories Ltd leads gainers in 'A' group
( Hot Pursuit - 10-Mar-21 12:00 )
Healthcare Global Enterprises Ltd Surges 4.7%
( Hot Pursuit - 03-May-21 09:30 )
Morepen Laboratories reports net loss of Rs 7.79 crore in the December 2012 quarter
( Results - Announcements 12-Feb-13 18:19 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
